An Interdisciplinary Program for In-House Counsel, Chief Officers, and Strategic Investors
Hosted by Dechert and Co-sponsored by Charles River Associates
Join us in Philadelphia on February 6 for 2024 Life Sciences Day, a half-day program exploring the current life sciences landscape, from development to post-launch litigation. Uncover the latest trends that are shaping the industry, gain invaluable legal insights from our seasoned experts, and arm yourself with robust risk avoidance strategies.
We will have an engaging fireside chat with Sir Gregory Paul Winter, a distinguished Nobel-Prize winning molecular biologist whose groundbreaking work has revolutionized the world of medicine and facilitated the development of many transformative life-saving therapies.
Sessions will include:
- Cybersecurity and privacy risks to life sciences companies, including the impact of AI on the threat landscape
- Recent developments in complex and securities litigation against life sciences companies
- How science can win a product liability case
- Considerations for an effective M&A strategy
- Managing multiple litigation fronts once you go to market
Timings:
11:45 a.m. – Registration
12:15 p.m. – Program
5:00 p.m. – Networking reception
Yajing Jiang is a panelist during the session titled “The M&A Play: Considerations for an Effective M&A Strategy.”
To learn more and RSVP to the event, click here.
